Metraipolis › archive › dc_8bde19005f0e

[Trastuzumab Deruxtecan for EGFR-mutant Lung Adenocarcinoma with Acquired High-level HER2 Amplification: A Case Report] — Europe PMC PMID:42124418

Source
Europe PMC (chi)
Original
https://europepmc.org/article/MED/42124418
DOI
10.3779/j.issn.1009-3419.2026.104.01
License (as archived)
solo-consultazione
Archived
2026-11-05T11:28:14.512Z
SHA-256 of the archived text
05544fcd32ff60c26b84b71bf4ae48d4be9c68c2b339459a0a4abbf8bca76e81
Stable URL of this page
https://metraipolis.com/documento/dc_8bde19005f0e

How to cite

[Trastuzumab Deruxtecan for EGFR-mutant Lung Adenocarcinoma with Acquired High-level HER2 Amplification: A Case Report] — Europe PMC PMID:42124418 — Europe PMC (chi), https://europepmc.org/article/MED/42124418 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8bde19005f0e (Metraipolis archive dc_8bde19005f0e, sha256 05544fcd32ff60c26b84b71bf4ae48d4be9c68c2b339459a0a4abbf8bca76e81)
BibTeX
@misc{dc8bde19005f0e,
  title = {[Trastuzumab Deruxtecan for EGFR-mutant Lung Adenocarcinoma with Acquired High-level HER2 Amplification: A Case Report] — Europe PMC PMID:42124418},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/42124418},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8bde19005f0e; sha256 05544fcd32ff60c26b84b71bf4ae48d4be9c68c2b339459a0a4abbf8bca76e81},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42124418. Agents can read the archived copy with the MCP tool read_document.